1. Home
  2. NEOG vs IMNM Comparison

NEOG vs IMNM Comparison

Compare NEOG & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neogen Corporation

NEOG

Neogen Corporation

HOLD

Current Price

$5.91

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$18.35

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEOG
IMNM
Founded
1981
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
1989
2020

Fundamental Metrics

Financial Performance
Metric
NEOG
IMNM
Price
$5.91
$18.35
Analyst Decision
Buy
Strong Buy
Analyst Count
4
9
Target Price
$8.83
$26.89
AVG Volume (30 Days)
3.6M
1.4M
Earning Date
01-09-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$886,886,000.00
$9,679,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.80
$85.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.87
$5.15
52 Week High
$14.26
$19.16

Technical Indicators

Market Signals
Indicator
NEOG
IMNM
Relative Strength Index (RSI) 46.94 60.55
Support Level $5.85 $17.96
Resistance Level $6.22 $18.96
Average True Range (ATR) 0.35 1.17
MACD -0.03 -0.02
Stochastic Oscillator 38.15 72.79

Price Performance

Historical Comparison
NEOG
IMNM

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: